Atul Agarwal

2.4k citations
81 papers · 1.7k indexed · h-index 28

Atul Agarwal

74 papers receiving 1.6k citations

Peers

Atul Agarwal
Comparison fields: 5 of 134
  • Hepatology 235
  • Molecular Medicine 91
  • Neurology 236
  • Infectious Diseases 277
  • Epidemiology 409
Replace Yahiya Y. Syed with:
Yahiya Y. Syed New Zealand
Martin Braun Germany
Wolfgang Reindl Germany
Yi Yang China
Haihong Zhu China
Maryam Nemati Iran
Georgios D. Lianos Greece
Jinsheng Yu United States
Atul Agarwal relative to Yahiya Y. Syed New Zealand Yahiya Y. Syed's profile →
Citations per field
00.5×1.5×1.9×
Yahiya Y. Syed · 1×
Citations per year

Countries citing papers authored by Atul Agarwal

Since Specialization
Citations

This map shows the geographic impact of Atul Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Agarwal more than expected).

Fields of papers citing papers by Atul Agarwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atul Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Agarwal. The network helps show where Atul Agarwal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Atul Agarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Atul Agarwal Line = papers co-authored together Atul Agarwal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20240
3 20240
4 20228
5 20212
6 20151
7 20135
8 20139
9 20122
10 201048
11 201038
12 200919
13 200738
14 20077
15 200713
16 20064
17 200625
18 200431
19 200344
20 199532

About Atul Agarwal

Atul Agarwal is a scholar working on Hepatology, Health Informatics, Molecular Medicine, Infectious Diseases and Virology, having authored 81 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (13 papers), HIV/AIDS drug development and treatment (8 papers), Infectious Diseases and Tuberculosis (7 papers), Antibiotic Resistance in Bacteria (6 papers), Fetal and Pediatric Neurological Disorders (5 papers), Advanced Neuroimaging Techniques and Applications (5 papers), Hepatitis B Virus Studies (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (5 papers). The work is most often cited by research in Hepatology (235 citations), Molecular Medicine (91 citations), Neurology (236 citations), Infectious Diseases (277 citations) and Epidemiology (409 citations). Atul Agarwal has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Ravindra Kumar Garg, Ethan Will Taylor, Rakesh K. Gupta, Rajesh Verma, Khader M. Hasan, Ponnada A. Narayana, Mazhar Husain, Mohammad Haris, Rakesh Shukla and Sona Saksena. Their work appears in journals such as Journal of Medicinal Chemistry, Academic Radiology, Journal of Hepatology, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026